These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 18587253

  • 1. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V, Babjuk M, Dusková J, Pesl M, Szakáczová M, Zámecník L, Dvorácek J.
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [Abstract] [Full Text] [Related]

  • 2. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
    Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Búcar S, Salinas D, Orsola I.
    Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
    [Abstract] [Full Text] [Related]

  • 3. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.
    Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340
    [Abstract] [Full Text] [Related]

  • 4. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
    Bi J, Chen X, Zhang Y, Li B, Sun J, Shen H, Kong C.
    Urol Oncol; 2012 Sep 01; 30(5):688-94. PubMed ID: 20888270
    [Abstract] [Full Text] [Related]

  • 5. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ, Fox SB, Newcomb PV, Persad RA, Sibley GN, Harris AL.
    J Urol; 1995 Jul 01; 154(1):237-41. PubMed ID: 7776437
    [Abstract] [Full Text] [Related]

  • 6. The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma.
    Bernardini S, Billerey C, Martin M, Adessi GL, Wallerand H, Bittard H.
    J Urol; 2001 Jan 01; 165(1):42-6; discussion 46. PubMed ID: 11125360
    [Abstract] [Full Text] [Related]

  • 7. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
    Tong GX, Yee H, Chiriboga L, Hernandez O, Waisman J.
    Hum Pathol; 2005 Jul 01; 36(7):741-6. PubMed ID: 16084942
    [Abstract] [Full Text] [Related]

  • 8. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M, Seisen T, Compérat E, Larré S, Mazerolles C, Gobet F, Fetissof F, Fromont G, Safsaf A, d'Arcier BF, Celhay O, Validire P, Rozet F, Irani J, Soulié M, Pfister C, Comité de Cancérologie de l'Association Française d'Urologie.
    J Urol; 2013 Jun 01; 189(6):2069-76. PubMed ID: 23201497
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jun 01; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 10. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 01; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar 01; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 12. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR.
    Cancer; 2004 May 01; 100(9):1859-67. PubMed ID: 15112266
    [Abstract] [Full Text] [Related]

  • 13. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec 01; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 14. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.
    Urology; 2007 Sep 01; 70(3):482-6. PubMed ID: 17905101
    [Abstract] [Full Text] [Related]

  • 15. [T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)].
    Faivre d'Arcier B, Celhay O, Safsaf A, Zairi A, Pfister C, Soulié M, Rozet F, Rouprêt M, Fromont G, Mazerolles C, Gobet F, Fetissof F, Irani J.
    Prog Urol; 2010 Jun 01; 20(6):440-9. PubMed ID: 20538209
    [Abstract] [Full Text] [Related]

  • 16. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.
    Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ.
    Urology; 2010 Jun 01; 75(6):1516.e9-13. PubMed ID: 19913893
    [Abstract] [Full Text] [Related]

  • 17. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov 01; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 18. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.
    Oncol Rep; 2006 Aug 01; 16(2):329-34. PubMed ID: 16820911
    [Abstract] [Full Text] [Related]

  • 19. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ, Wasco MJ, Wang R, Daignault S, Lee CT, Shah RB.
    J Urol; 2009 Jul 01; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB, Zeng FH, Sun ZQ.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.